Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzathine Penicillin Combined With Etanercept for Spondyloarthritis
NCT06707194Phase 4Recruiting
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jun 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Benzathine penicillin in spondyloarthritis (SpA), ankylosing spondylitis (AS), sponsored by Nanfang Hospital, Southern Medical University. Started Jun 2025; status: recruiting.
02
Drugs
Benzathine penicillin
03
Conditions
spondyloarthritis (SpA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT06707194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06707194.